TY - JOUR A1 - Nedopil, Alexander J. A1 - Dhaliwal, Anand A1 - Howell, Stephen M. A1 - Hull, Maury L. T1 - A surgeon that switched to unrestricted kinematic alignment with manual instruments has a short learning curve and comparable resection accuracy and outcomes to those of an experienced surgeon JF - Journal of Personalized Medicine N2 - After starting an orthopedic practice, a surgeon with a fellowship in mechanically aligned (MA) TKA initiated this study to characterize their learning curve after they switched to unrestricted kinematic alignment (KA) TKA using manual instruments. Accordingly, the present study determined for the inexperienced (IE) surgeon the number of cases required to achieve consistent femoral resections and operating times, and whether the femoral resection accuracy, patient-reported outcome measures (PROMs), and component alignment were different from an experienced (E) surgeon. This prospective cohort study analyzed the IE surgeon's first 30 TKAs, all performed with KA, and 30 consecutive KA TKAs performed by an E surgeon. The resection accuracy or deviation was the calipered thickness of the distal and posterior medial and lateral femoral resections minus the planned resection thickness, which was the thickness of the corresponding condyle of the femoral component, minus 2 mm for cartilage wear, and 1 mm for the kerf of the blade. Independent observers recorded the femoral resection thickness, operative times, PROMs, and alignment. For each femoral resection, the deviation between three groups of patients containing ten consecutive KA TKAs, was either insignificant (p = 0.695 to 1.000) or within the 0.5 mm resolution of the caliper, which indicated no learning curve. More than three groups were needed to determine the learning curve for the operative time; however, the IE surgeon's procedure dropped to 77 min for the last 10 patients, which was 20 min longer than the E surgeon. The resection deviations of the IE and E surgeon were comparable, except for the posterolateral femoral resection, which the IE surgeon under-resected by a mean of −0.8 mm (p < 0.0001). At a mean follow-up of 9 and 17 months, the Forgotten Joint Score, Oxford Knee Score, KOOS, and the alignment of the components and limbs were not different between the IE and E surgeon (p ≥ 0.6994). A surgeon that switches to unrestricted KA with manual instruments can determine their learning curve by computing the deviation of the distal and posterior femoral resections from the planned resection. Based on the present study, an IE surgeon could have resection accuracy, post-operative patient outcomes, and component alignment comparable to an E surgeon. KW - total knee arthroplasty KW - kinematic alignment KW - learning curve KW - accuracy KW - efficiency Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-281842 SN - 2075-4426 VL - 12 IS - 7 ER - TY - JOUR A1 - Horas, Konstantin A1 - van Herck, Ulrike A1 - Maier, Gerrit S. A1 - Maus, Uwe A1 - Harrasser, Norbert A1 - Jakob, Franz A1 - Weissenberger, Manuel A1 - Arnholdt, Jörg A1 - Holzapfel, Boris M. A1 - Rudert, Maximilian T1 - Does vitamin D deficiency predict tumour malignancy in patients with bone tumours? Data from a multi-center cohort analysis JF - Journal of Bone Oncology N2 - Vitamin D deficiency is a global health concern that is estimated to afflict over one billion people globally. The major role of vitamin D is that of a regulator of calcium and phosphate metabolism, thus, being essential for proper bone mineralisation. Concomitantly, vitamin D is known to exert numerous extra-skeletal actions. For example, it has become evident that vitamin D has direct anti-proliferative, pro-differentiation and pro-apoptotic actions on cancer cells. Hence, vitamin D deficiency has been associated with increased cancer risk and worse prognosis in several malignancies. We have recently demonstrated that vitamin D deficiency promotes secondary cancer growth in bone. These findings were partly attributable to an increase in bone remodelling but also through direct effects of vitamin D on cancer cells. To date, very little is known about vitamin D status of patients with bone tumours in general. Thus, the objective of this study was to assess vitamin D status of patients with diverse bone tumours. Moreover, the aim was to elucidate whether or not there is an association between pre-diagnostic vitamin D status and tumour malignancy in patients with bone tumours. In a multi-center analysis, 25(OH)D, PTH and calcium levels of 225 patients that presented with various bone tumours between 2017 and 2018 were assessed. Collectively, 76% of all patients had insufficient vitamin D levels with a total mean 25(OH)D level of 21.43 ng/ml (53.58 nmol/L). In particular, 52% (117/225) of patients were identified as vitamin D deficient and further 24% of patients (55/225) were vitamin D insufficient. Notably, patients diagnosed with malignant bone tumours had significantly lower 25(OH)D levels than patients diagnosed with benign bone tumours [19.3 vs. 22.75 ng/ml (48.25 vs. 56.86 nmol/L); p = 0.04). In conclusion, we found a widespread and distressing rate of vitamin D deficiency and insufficiency in patients with bone tumours. However, especially for patients with bone tumours sufficient vitamin D levels seem to be of great importance. Thus, we believe that 25(OH)D status should routinely be monitored in these patients. Collectively, there should be an increased awareness for physicians to assess and if necessary correct vitamin D status of patients with bone tumours in general or of those at great risk of developing bone tumours. KW - bone tumour KW - vitamin D KW - hypovitaminosis D KW - vitamin D deficiency KW - malignancy KW - tumour malignancy Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-230314 VL - 25 ER - TY - JOUR A1 - Ohlebusch, Barbara A1 - Borst, Angela A1 - Frankenbach, Tina A1 - Klopocki, Eva A1 - Jakob, Franz A1 - Liedtke, Daniel A1 - Graser, Stephanie T1 - Investigation of alpl expression and Tnap-activity in zebrafish implies conserved functions during skeletal and neuronal development JF - Scientific Reports N2 - Hypophosphatasia (HPP) is a rare genetic disease with diverse symptoms and a heterogeneous severity of onset with underlying mutations in the ALPL gene encoding the ectoenzyme Tissue-nonspecific alkaline phosphatase (TNAP). Considering the establishment of zebrafish (Danio rerio) as a new model organism for HPP, the aim of the study was the spatial and temporal analysis of alpl expression in embryos and adult brains. Additionally, we determined functional consequences of Tnap inhibition on neural and skeletal development in zebrafish. We show that expression of alpl is present during embryonic stages and in adult neuronal tissues. Analyses of enzyme function reveal zones of pronounced Tnap-activity within the telencephalon and the mesencephalon. Treatment of zebrafish embryos with chemical Tnap inhibitors followed by axonal and cartilage/mineralized tissue staining imply functional consequences of Tnap deficiency on neuronal and skeletal development. Based on the results from neuronal and skeletal tissue analyses, which demonstrate an evolutionary conserved role of this enzyme, we consider zebrafish as a promising species for modeling HPP in order to discover new potential therapy strategies in the long-term. KW - nonspecific alkaline-phosphae KW - in situ hybridization KW - hypophosphatasia KW - promotes KW - model KW - neurotransmission KW - differentiation KW - mineraliztion KW - metabolism KW - vertebrate Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-230024 VL - 10 ER - TY - JOUR A1 - Reichel, Thomas A1 - Rueckl, Kilian A1 - Fenwick, Annabel A1 - Vogt, Niklas A1 - Rudert, Maximilian A1 - Plumhoff, Piet T1 - Hibernoma of the upper extremity: complete case of a rare but benign soft tissue tumor JF - Case Reports in Orthopedics N2 - Hibernoma is a rare benign lipomatous tumor showing differentiation of brown fatty tissue. To the author’s best knowledge, there is no known case of malignant transformation or metastasis. Due to their slow, noninfiltrating growth hibernomas are often an incidental finding in the third or fourth decade of life. The vast majority are located in the thigh, neck, and periscapular region. A diagnostic workup includes ultrasound and contrast-enhanced MRI. Differential diagnosis is benign lipoma, well-differentiated liposarcoma, and rhabdomyoma. An incisional biopsy followed by marginal resection of the tumor is the standard of care, and recurrence after complete resection is not reported. The current paper presents diagnostic and intraoperative findings of a hibernoma of the upper arm and reviews similar reports in the current literature. KW - benige tumor Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-201669 VL - 2019 ER - TY - THES A1 - Ege, Carolin T1 - Einfluss der Phosphodiesterase 10A auf cAMP-abhängige Signalwege und deren Effekt auf osteogene Differenzierung und Mechanotransduktion von mesenchymalen Stromazellen T1 - Influence of phosphodiesterase 10A on cAMP-dependent signaling pathways and their effect on osteogenic differentiation and mechanotransduction of mesenchymal stromal cells N2 - Humane mesenchymale Stromazellen sind in der Lage in osteogene Zellen zu differenzieren, und für diese osteogene Differenzierung ist mechanische Belastung ein relevanter Kostimulus. Mechanotransduktion hat zur Folge, dass second messenger wie cAMP und cGMP gebildet werden und sich die Ca2+-Konzentration erhöht, welche wiederum Transkriptionsfaktoren aktivieren, die die Regulation von Genen osteogener Marker vermitteln. Die second messenger cAMP und cGMP werden abgebaut durch Phosphodiesterasen, jedoch ist die Rolle dieser Phosphodiesterasen während der osteogenen Differenzierung oder Mechanotransduktion weiterhin unklar. Das Ziel dieser Arbeit war es, herauszufinden, inwieweit im Besonderen die Phosphodiesterase 10A einen Einfluss nimmt auf die osteogene Differenzierung und die Mechanotransduktion von mesenchymalen Stromazellen und inwiefern sie dabei die cAMP-abhängigen Signalwege moduliert. Langfristig soll hiermit herausgefunden wer-den, welche Bedeutung die PDE10A auf altersinduzierte Krankheiten hat, wobei der Fokus zunächst auf der Osteoporose liegen soll. Um dies zu erreichen, wurden experimentelle Versuche zunächst mit HEK293- und hMSC-TERT-Zellen als Modell für mesenchymale Stromazellen durchgeführt, dann auch mit den mesenchymalen Stromazellen selbst. Untersucht wurde der Einfluss des PDE10A-Inhibitors Papaverin auf die Zellen und auf deren mechanische Induzierbarkeit, sowieso auf die osteogene Differenzierung der hMSC. Außerdem wurden weitere mechanische Versuche durchgeführt, zur Überprüfung des Effekts der Phosphodiesterase 10A. Es wurde beobachtet, dass die Inhibierung von PDE10A mit Papaverin die osteogene Differenzierung und Mineralisierung vermindert. Außerdem gab es einen ersten Hinweis, dass eine Überexpression von PDE10A schwächenden Einfluss nimmt auf die Expression mechanoresponsiver Gene. Nachfolgend auf diese Arbeit wurde erkannt, dass die Expression von mechanoresponsiven Genen durch die PDE10A-Inhibition unterdrückt wird. N2 - Human mesenchymal stromal cells are able to differentiate into osteogenic cells, and for this osteogenic differentiation mechanical stress is a relevant costimulus. Mechanotransduction results in the formation of second messengers such as cAMP and cGMP and an increase in Ca2+ concentration, which in turn activate transcription factors that mediate the regulation of osteogenic marker genes. The second messengers cAMP and cGMP are degraded by phosphodiesterases, but the role of these phosphodiesterases during osteogenic differentiation or mechanotransduction remains unclear. The aim of this work was to determine to what extent phosphodiesterase 10A in particular influences osteogenic differentiation and mechanotransduction of mesenchymal stromal cells and to what extent it modulates cAMP-dependent signaling pathways. In the long term, the aim is to find out what role PDE10A plays in age-related diseases, with an initial focus on osteoporosis. To achieve this, experimental trials were first performed using HEK293 and hMSC-TERT cells as a model for mesenchymal stromal cells, and then also using the mesenchymal stromal cells themselves. The influence of the PDE10A inhibitor papaverine on the cells and on their mechanical inducibility, as well as on the osteogenic differentiation of hMSC was investigated. In addition, further mechanical experiments were performed, to verify the effect of phosphodiesterase 10A. It was observed that inhibition of PDE10A with papaverine decreased osteogenic differentiation and mineralization. In addition, there was initial evidence that overexpression of PDE10A has a debilitating effect on the expression of mechanoresponsive genes. Subsequent to this work, it was recognized that the expression of mechanoresponsive genes is suppressed by PDE10A inhibition. KW - Mesenchymzelle KW - Osteoporose KW - Cyclisches Nucleotid Phosphodiesterase <3,5-> KW - Papaverin KW - Mechanotransduktion KW - Phosphodiesterase 10A KW - cAMP KW - MSC KW - Mesenchymale Stromazellen Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-328327 ER - TY - JOUR A1 - Pereira, Ana Rita A1 - Lipphaus, Andreas A1 - Ergin, Mert A1 - Salehi, Sahar A1 - Gehweiler, Dominic A1 - Rudert, Maximilian A1 - Hansmann, Jan A1 - Herrmann, Marietta T1 - Modeling of the Human Bone Environment: Mechanical Stimuli Guide Mesenchymal Stem Cell−Extracellular Matrix Interactions JF - Materials N2 - In bone tissue engineering, the design of in vitro models able to recreate both the chemical composition, the structural architecture, and the overall mechanical environment of the native tissue is still often neglected. In this study, we apply a bioreactor system where human bone-marrow hMSCs are seeded in human femoral head-derived decellularized bone scaffolds and subjected to dynamic culture, i.e., shear stress induced by continuous cell culture medium perfusion at 1.7 mL/min flow rate and compressive stress by 10% uniaxial load at 1 Hz for 1 h per day. In silico modeling revealed that continuous medium flow generates a mean shear stress of 8.5 mPa sensed by hMSCs seeded on 3D bone scaffolds. Experimentally, both dynamic conditions improved cell repopulation within the scaffold and boosted ECM production compared with static controls. Early response of hMSCs to mechanical stimuli comprises evident cell shape changes and stronger integrin-mediated adhesion to the matrix. Stress-induced Col6 and SPP1 gene expression suggests an early hMSC commitment towards osteogenic lineage independent of Runx2 signaling. This study provides a foundation for exploring the early effects of external mechanical stimuli on hMSC behavior in a biologically meaningful in vitro environment, opening new opportunities to study bone development, remodeling, and pathologies. KW - bone tissue engineering KW - human trabecular bone decellularization KW - in vitro modeling KW - shear stress KW - compressive load KW - fluid simulation KW - cell-matrix interaction KW - mechanotransduction Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-245012 SN - 1996-1944 VL - 14 IS - 16 ER - TY - JOUR A1 - Seefried, L. A1 - Rak, D. A1 - Petryk, A. A1 - Genest, F. T1 - Bone turnover and mineral metabolism in adult patients with hypophosphatasia treated with asfotase alfa JF - Osteoporosis International N2 - Summary There is limited understanding of how asfotase alfa affects mineral metabolism and bone turnover in adults with pediatric-onset hypophosphatasia. This study showed that adults with hypophosphatasia treated with asfotase alfa experienced significant changes in biochemical markers of bone and mineral metabolism, possibly reflecting enhanced bone remodeling of previously osteomalacic bone. Introduction Hypophosphatasia (HPP), due to a tissue nonspecific alkaline phosphatase (TNSALP) deficiency, can cause impaired bone mineralization and turnover. Although HPP may be treated with asfotase alfa, an enzyme replacement therapy, limited data are available on how treatment with asfotase alfa affects mineral metabolism and bone turnover in adults with HPP. Methods ALP substrates, bone turnover and mineral metabolism markers, and bone mineral density (BMD) data from EmPATHY, a single-center, observational study of adults (≥ 18 years) with pediatric-onset HPP treated with asfotase alfa (NCT03418389), were collected during routine clinical care and analyzed from baseline through 24 months of treatment. Results Data from 21 patients showed significantly increased ALP activity and reduced urine phosphoethanolamine (PEA)/creatinine (Cr) ratios after baseline through 24 months of asfotase alfa treatment. There were significant transient increases in parathyroid hormone 1-84 (PTH), osteocalcin, and procollagen type 1 N-propeptide (P1NP) levels at 3 and 6 months and in tartrate-resistant acid phosphatase 5b (TRAP5b) levels at 3 months, with a significant decrease in N-terminal telopeptide of type 1 collagen (NTX) levels at 24 months. Lumbar spine BMD T scores continuously increased during treatment. Conclusion Significant changes in bone turnover and mineral metabolism markers after asfotase alfa treatment suggest that treatment-mediated mineralization may enable remodeling and bone turnover on previously unmineralized surfaces. Urine PEA/Cr ratios may be a useful parameter in monitoring treatment during routine care. KW - bone mineral density KW - bone turnover KW - hypophosphatasia KW - enzyme replacement therapy KW - alkaline phosphatase Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-265310 VL - 32 IS - 12 ER - TY - JOUR A1 - Genest, F. A1 - Claußen, L. A1 - Rak, D. A1 - Seefried, L. T1 - Bone mineral density and fracture risk in adult patients with hypophosphatasia JF - Osteoporosis International N2 - Summary In adult hypophosphatasia (HPP) patients, elevated lumbar spine dual X-ray absorptiometry (DXA) values are associated with markers of disease severity and disease-specific fracture risk while femoral bone mineral density (BMD), being largely unaffected by the disease severity, may still be useful to monitor other causes of increased fracture risk due to low BMD. Introduction Hypophosphatasia (HPP) is a rare inherited metabolic disorder due to deficient activity of the tissue-nonspecific alkaline phosphatase (TNAP). Clinical manifestation in adult HPP patients is manifold including an increased risk for fractures, but data regarding clinical significance of DXA measurement and associations with fracture risk and disease severity is scarce. Methods Retrospective single-center analysis of DXA scans in patients with confirmed HPP (documented mutation, clinical symptoms, low alkaline phosphatase activity). Further data evaluation included disease-related fractures, laboratory results (alkaline phosphatase, pyridoxalphosphate, phosphoethanolamine), and medical history. Results Analysis included 110 patients (84 female, mean age of 46.2 years) of whom 37.3% (n = 41) were harboring two mutations. Average T-Score level at the lumbar spine was − 0.1 (SD 1.9), and mean total hip T-Score was − 1.07 (SD 0.15). Both lower ALP activity and higher substrate levels (pyridoxalphosphate and phosphoethanolamine) were significantly correlated with increased lumbar spine T-Score levels (p < 0.001) while BMD at the hip was not affected by indicators of disease severity. Increased lumbar spine BMD was significantly associated with an increased risk for HPP-related fractures, prevalent in 22 (20%) patients (p < 0.001) with 21 of them having biallelic mutations. Conclusion BMD in adult HPP patients is not systematically reduced. Conversely, increased lumbar spine BMD appears to be associated with severely compromised mineralization and increased risk for HPP-related fractures while BMD at the hip appears unaffected by indicators of disease severity, suggesting suitability of this anatomic location for assessing and discerning disorders with increased fracture risk owing to reduced BMD like osteoporosis. Trial registration number German register for clinical studies (DRKS00014022) Date of registration 02/10/2018 – retrospectively registered KW - bone mineral density KW - fracture risk KW - hypophosphatasia KW - osteoporosis KW - pseudofracture Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-235793 SN - 0937-941X VL - 32 ER - TY - JOUR A1 - Stratos, Ioannis A1 - Behrendt, Ann-Kathrin A1 - Anselm, Christian A1 - Gonzalez, Aldebarani A1 - Mittlmeier, Thomas A1 - Vollmar, Brigitte T1 - Inhibition of TNF-α restores muscle force, inhibits inflammation, and reduces apoptosis of traumatized skeletal muscles JF - Cells N2 - Background: Muscle injuries are common in humans and are often associated with irrecoverable damage and disability. Upon muscle injury, TNF-α signaling pathways modulate the healing process and are predominantly associated with tissue degradation. In this study we assumed that TNF-α inhibition could reduce the TNF-α-associated tissue degradation after muscle injury. Materials and methods: Therefore, the left soleus muscle of 42 male Wistar rats was injured using a standardized open muscle injury model. All rats were treated immediately after injury either with infliximab (single i.p. injection; 10 mg/kg b.w.) or saline solution i.p. Final measurements were conducted at day one, four, and 14 post injury. The muscle force, the muscle cell proliferation, the muscle cell coverage as well as the myofiber diameter served as read out parameters of our experiment. Results: Systemic application of infliximab could significantly reduce the TNF-α levels in the injured muscle at day four upon trauma compared to saline treated animals. The ratio of muscle weight to body weight was increased and the twitch muscle force showed a significant rise 14 days after trauma and TNF-α inhibition. Quantification of myofiber diameter in the penumbra zone showed a significant difference between both groups at day one and four after injury, indicated by muscle hypertrophy in the infliximab group. Planimetric analysis of the injured muscle at day 14 revealed increased muscle tissue fraction in the infliximab group compared to the control animals. Muscle cell proliferation did not differ between both groups. Conclusions: These data provide evidence that the TNF-α blockade positively regulates the restauration of skeletal muscles upon injury. KW - muscle injury KW - regeneration KW - infliximab KW - tumor necrosis factor alpha Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-286094 SN - 2073-4409 VL - 11 IS - 15 ER - TY - THES A1 - Weissenberger [geb. Kunz], Manuela-Hermina T1 - Adenoviraler Gentransfer von SOX9 zur chondrogenen Differenzierung von humanen mesenchymalen Stammzellen T1 - Adenoviral gene transfer of SOX9 for chondrogenic differentiation of human mesenchymal stem cells N2 - Der adenovirale SOX9-Gentransfer induziert nach 3-wöchiger in vitro Pelletkultur die chondrogene Differenzierung humaner mesenchymaler Stammzellen in Pelletkultur wirksamer als der TGFB1 Gentransfer mit geringerer Chondrozytenhypertrophie. Eine solche Technologie könnte zukünftig in vivo die Bildung von stabilerem hyalinem Knorpelregeneratgewebe ermöglichen. N2 - Adenoviral SOX9 genetransfer in human mesenchymal stem cells can be used for chondrogenic differentiation and to generate stable hyaline cartilage regeneration in vitro in pellet culture system. KW - Hyaliner Knorpel KW - Adenoviraler Gentransfer KW - Knorpelregeneration KW - Stammzellen KW - chondrogene Differenzierung KW - SOX9 KW - Stammzelle Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-321221 ER - TY - THES A1 - Strömsdörfer, Johanna T1 - Einfluss von Vibrationstraining auf körperliche Leistungsfähigkeit, Alltagsaktivität und Lebensqualität von Patienten mit monoklonaler Gammopathie T1 - Impact of whole-body vibration exercise on physical performance, daily activity and quality of life in patients with monoclonal gammopathy of undetermined significance N2 - Patienten mit monoklonaler Gammopathie unklarer Signifikanz haben ein erhöhtes Risiko an einer Osteoporose, Knochenbrüchen oder einer reduzierten Leistungsfähigkeit zu leiden. Bisher hat sich noch keine Therapie zur Prävention dieser Komplikationen etabliert. Das Ziel unserer Studie war es, WBV als eine mögliche Trainingsmethode zu prüfen und den Einfluss auf die Fitness, Alltagsaktivität und Lebensqualität von Patienten mit monoklonaler Gammopathie zu untersuchen. Hierfür haben 15 Probanden mit MGUS/SMM ein Trainingsprogramm über 3 bzw. 6 Monate mit zwei Trainingseinheiten pro Woche für jeweils 30 Minuten absolviert. Die körperliche Leistungsfähigkeit wurde anhand verschiedener Funktionstests sowie der Erhebung von Körpermaßen betrachtet. Die Alltagsaktivität wurde mittels Fitnesstrackern untersucht. Anhand von 3 verschiedenen Fragebögen wurde zudem der Einfluss auf die Lebensqualität der Probanden durch das Training ermittelt. Zusammenfassend zeigte sich eine deutliche Verbesserung der Fitness und Ausdauer der Probanden, die Alltagsaktivität und die Lebensqualität wurden nicht durch das Vibrationstraining beeinflusst. N2 - Patients with monoclonal gammopathy of undetermined significance have an increased risk of suffering from osteoporosis, bone fractures or reduced physical performance. So far, no therapy has been established to prevent these complications. The aim of our study was to evaluate WBV as a possible training method and to investigate its impact on physical performance, daily activity and quality of life in patients with monoclonal gammopathy. For this purpose, 15 subjects with MGUS/SMM completed an exercise program for 3 and 6 months, with two training sessions per week for 30 minutes each. Physical performance was considered by means of various functional tests as well as the collection of body measurements. Daily activity was examined by means of fitness trackers. In addition, the influence of the training on the quality of life of the test persons was determined by means of 3 different questionnaires. In summary, there was a significant improvement in the physical performance, the daily activity and quality of life were not influenced by the vibration training. KW - Vibrationstraining KW - Monoklonale Gammopathie KW - Körperliche Leistungsfähigkeit KW - unklarer Signifikanz Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-320895 ER - TY - THES A1 - Altmann, Stephan T1 - Characterization of Metabolic Glycoengineering in Mesenchymal Stromal Cells for its Application in thermoresponsive Bioinks T1 - Charakterisierung von Metabolic Glycoengineering in mesenchymalen Stromazellen für die Anwendung in thermoresponsiven Biotinten N2 - This work developed during the first funding period of the subproject B05 in the framework of the interdisciplinary research consortium TRR 225 ‘From the Fundamentals of Biofabrication toward functional Tissue Models’ and was part of a cooperation between the Orthopedic Department represented by Prof. Dr. Regina Ebert and the Institute of Organic Chemistry represented by Prof. Dr. Jürgen Seibel. This project dealed with cellular behavior during the bioprinting process and how to influence it by modifying the cell glycocalyx with functional target molecules. The focus was on the impact of potential shear stress, that cells experience when they get processed in thermoresponsive bioinks, and a way to increase the cell stiffness via metabolic glycoengineering to attenuate shear forces. For the characterization of the metabolic glycoengineering, four different peracetylated and four non-acetylated modified monosaccharides (two mannose and two sialic acid sugars) were tested in primary human mesenchymal stromal cells (hMSC) and telomerase-immortalized hMSC (hMSC-TERT). Viability results demonstrated a dose-dependent correlation for all sugars, at which hMSC-TERT seemed to be more susceptible leading to lower viability rates. The assessment of the incorporation efficiencies was performed by click chemistry using fluorescent dyes and revealed also a dose-dependent correlation for all mannose and sialic acid sugars, while glucose and galactose variants were not detected in the glycocalyx. However, incorporation efficiencies were highest when using mannose sugars in the primary hMSC. A subsequent analysis of the temporal retention of the incorporated monosaccharides showed a constant declining fluorescence signal up to 6 d for azido mannose in hMSC-TERT, whereas no signal could be detected for alkyne mannose after 2 d. Investigation of the differentiation potential and expression of different target genes revealed no impairment after incubation with mannose sugars, indicating a normal phenotype for hMSC-TERT. Following the successful establishment of the method, either a coumarin derivative or an artificial galectin 1 ligand were incorporated into the cell glycocalyx of hMSC-TERT as functional target molecule. The biophysical analysis via shear flow deformation cytometry revealed a slightly increased cell stiffness and lowered fluidity for both molecules. A further part of this project aimed to control lectin-mediated cell adhesion by artificial galectin 1 ligands. As that hypothesis was settled in the work group of Prof. Dr. Jürgen Seibel, this work supported with an initial characterization of galectin 1 as part of the hMSC biology. A stable galectin 1 expression at gene and protein level in both hMSC and hMSC-TERT could be confirmed, at which immunocytochemical stainings could detect the protein only in the glycocalyx. The treatment of hMSC-TERT with a galectin 1 ligand in different concentrations did not show an altered gene expression of galectin 1. However, these first data in addition to the investigation of stiffness confirmed the applicability of specific and artificial IV galectin 1 ligands in biofabrication approaches to alter cell properties of hMSC. To conclude, metabolic glycoengineering has been successfully implemented in hMSC and hMSC-TERT to introduce glycocalyx modifications which reside there for several days. A proof of concept was carried out by the increase of cell stiffness and fluidity by the incorporation of a coumarin derivative or an artificial galectin 1 ligand. For the characterization of shear stress impact on cells after printing in thermoresponsive bioinks, the processing of hMSC-TERT (mixing or additionally printing) with Pluronic F127 or Polyoxazoline-Polyoxazine (POx-POzi) polymer solution was investigated. While there were no changes in viability when using POx-POzi bioink, processing with Pluronic F127 indicated slightly lower viability and increased apoptosis activity. Assessment of cellular responses to potential shear stress showed no reorganization of the cytoskeleton independent of the bioink, but highly increased expression of the mechanoresponsive proto-oncogene c Fos which was more pronounced when using Pluronic F127 and just mixed with the bioinks. Interestingly, processing of the mechanoresponsive reporter cell line hMSC-TERT-AP1 revealed slightly elevated mechanotransduction activity when using POx-POzi polymer and just mixed with the bioinks as well. In conclusion, hMSC-TERT embedded in thermoresponsive bioinks might shortly experience shear stress during the printing process, but that did not lead to remarkable cell damage likely due to the rheological properties of the bioinks. Furthermore, the printing experiments also suggested that cells do not sense more shear stress when additionally printed. N2 - Diese Arbeit entstand aus dem Projekt B05 während der ersten Förderperiode im Rahmen des interdisziplinären Sonderforschungsbereiches TRR 225 „Von den Grundlagen der Biofabrikation zu funktionalen Gewebemodellen“ und beinhaltete eine Kooperation zwischen dem Lehrstuhl für Orthopädie repräsentiert durch Prof. Dr. Regina Ebert und dem Institut für Organische Chemie repräsentiert durch Prof. Dr. Jürgen Seibel. Das Projekt beschäftigte sich mit den Auswirkungen des 3D Drucks auf Zellen während und nach dem Druck mit thermoresponsiven Biotinten. Hierbei lag der Fokus auf Scherkräften, die Zellen während des Drucks erfahren, und der Möglichkeit, deren nachteilige Auswirkungen durch gezielte Erhöhung der Zellsteifigkeit via Metabolic Glycoengineering zu minimieren. Zur Etablierung dieser Methode wurden vier azetylierte sowie vier nicht-azetylierte modifizierte Einfachzucker (zwei Mannosen und zwei Sialinsäuren) hinsichtlich ihrer Zellkompatibilität und Einbaurate in primären humanen mesenchymalen Stromazellen (hMSC) und Telomerase-immortalisierten hMSC (hMSC-TERT) charakterisiert. Bei der Viabilität zeigte sich für alle untersuchten Zucker ein konzentrationsabhängiges Verhalten, wobei die hMSC-TERT generell empfindlicher reagierten. Eine Untersuchung von verschiedenen Zielgenen nach Zuckerinkubation gab keine Hinweise auf biologisch veränderte Expressionsmuster und auch das phänotypische Differenzierungspotenzial (adipogen und osteogen) blieb erhalten. Der Einbau der modifizierten Zucker in Proteoglykane sowie Glykoproteine der Glykokalyx wurde mikroskopisch mittels Fluoreszenzfarbstoffen charakterisiert. Dabei zeigte sich ebenfalls ein konzentrationsabhängiges Verhalten für alle Mannosen und Sialinsäuren, wohingegen die Glukose- und Galaktosevarianten nicht nachgewiesen werden konnten. Die Mannosezucker zeigten die höchsten Einbauraten, welche in primären hMSC noch stärker ausfielen als in hMSC-TERT. Ein Langzeitversuch zur Beurteilung der zeitlichen Stabilität der Glykokalyxmodifikation konnte für die azetylierte Azidomannose ein abnehmendes Fluoreszenzsignal bis zum sechsten Tag nach der Klickreaktion ermitteln. Im Gegensatz dazu konnte die azetylierte Alkinmannose bereits ab dem zweiten Tag nicht mehr nachgewiesen werden. Nach der erfolgreichen Optimierung der Methodik wurde der Effekt eines Kumarinderivates oder eines künstlichen Galektin 1 Liganden auf die Zellsteifigkeit sowie die -fluidität mit Hilfe der Deformationszytometrie untersucht. Die Modifikation der Glykokalyx mit beiden untersuchten Molekülen führte zu einer leichten Erhöhung der Steifigkeit in Kombination mit einer leicht erniedrigten Fluidität. In einem weiteren Teil des Projekts sollte die Lektin-vermittelte Adhäsion von Zellen an Polymerstränge initiiert werden, indem sie mit künstlichen Galektin 1 Liganden modifiziert werden. Da diese Hypothese in der Forschungsgruppe von Prof. Dr. Jürgen Seibel bearbeitet wurde, unterstützte diese Arbeit mit einer anfänglichen Charakterisierung von Galektin 1 als Teil der hMSC Zellbiologie. In hMSC und hMSC-TERT konnte eine VI stabile Expression auf Gen- und Proteinebene nachwiesen werden, wobei das Lektin in der Glykokalyx lokalisiert war. Ein Inkubationsversuch mit einem spezifischen Liganden zeigte in hMSC-TERT unabhängig von der Konzentration keine veränderte Galektin 1 Genexpression. In Verbindung mit den Steifigkeitsuntersuchungen bestätigt diese anfängliche Charakterisierung die Anwendbarkeit von künstlichen Galektin 1 Liganden in der Biofabrikation um hMSC zu modifizieren. Somit konnte gezeigt werden, dass Metabolic Glycoengineering sich für die gezielte Einbringung von Molekülen in die Zellglykokalyx von primären hMSC sowie der entsprechenden TERT-Zelllinie zur mittelfristigen Modifikation eignet. Dies wurde durch einen funktionellen Ansatz bestätigt, indem die Zellsteifigkeit und -fluidität durch den Einsatz zwei verschiedener Moleküle erwartungsgemäß beeinflusst wurden. Für die Charakterisierung der Scherstressauswirkungen auf Zellen nach 3D Druck in thermoresponsiven Biotinten wurden hMSC und hMSC-TERT in Pluronic F127 oder Polyoxazolin-Polyoxazin (POx-POzi) Polymerlösung prozessiert (gemischt oder zusätzlich verdruckt) und direkt danach analysiert. Während letztere die Viabilität nicht verschlechterte, zeigten hMSC-TERT nach Verarbeitung in Pluronic F127 eine leicht erniedrigte Viabilität sowie leicht erhöhte Apoptoseraten. Im Zuge von Analysen der Mechanotransduktion und deren Auswirkungen konnte unabhängig von der Biotinte sowie der Behandlung kein Umbau des Zytoskeletts immunzytochemisch nachgewiesen werden. Im Gegensatz dazu zeigten Genexpressionsanalysen eine starke Hochregulierung des mechanoresponsiven Proto-Onkogens c Fos unter allen Bedingungen, wobei diese stärker ausfiel bei Verwendung der Pluronic F127 Biotinte und nur nach Mischen (gilt für beide Biotinten). Um den Scherstress quantitativ zu beurteilen, wurde die Reporterzelllinie hMSC-TERT-AP1 verwendet, welche das Auslesen der Mechanotransduktion durch eine gekoppelte Luziferase-Proteinexpression ermöglicht. Interessanterweise zeigte sich eine leicht erhöhte Luziferaseaktivität nur nach Verarbeitung mit der POx-POzi Polymerlösung, welche stärker ausfiel wenn die Zellen mit der Biotinte lediglich gemischt wurden. Zusammengenommen bestätigten die Ergebnisse die zelluläre Wahrnehmung von Scherstress in thermoresponsiven Biotinten, allerdings scheint dieser nur schwache Auswirkungen auf die Zellen zu haben, was auf die rheologischen Eigenschaften beider untersuchten Biotinten zurückgeführt werden kann. Die Druckergebnisse legten außerdem nahe, dass die Zellen nicht mehr Scherstress erfahren, wenn sie zusätzlich verdruckt wurden. KW - Glykobiologie KW - Glykokalyx KW - Tissue Engineering KW - Galectine KW - Metabolic Glycoengineering KW - Biofabrication KW - Galectin 1 KW - Glycocalyx KW - Shear Stress KW - Scherstress Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-291003 ER - TY - JOUR A1 - Rak, Dominik A1 - Nedopil, Alexander J. A1 - Sayre, Eric C. A1 - Masri, Bassam A. A1 - Rudert, Maximilian T1 - Postoperative inpatient rehabilitation does not increase knee function after primary total knee arthroplasty JF - Journal of Personalized Medicine N2 - Inpatient rehabilitation (IR) is a common postoperative protocol after total knee replacement (TKA). Because IR is expensive and should therefore be justified, this study determined the difference in knee function one year after TKA in patients treated with IR or outpatient rehabilitation, fast-track rehabilitation (FTR) in particular, which also entails a reduced hospital length of stay. A total of 205 patients were included in this multi-center prospective cohort study. Of the patients, 104 had primary TKA at a German university hospital and received IR, while 101 had primary TKA at a Canadian university hospital and received FTR. Patients receiving IR or FTR were matched by pre-operative demographics and knee function. Oxford Knee Score (OKS), Western Ontario and McMaster Universities Arthritis Index (WOMAC), and EuroQol visual analogue scale (EQ-VAS) determined knee function one year after surgery. Patients receiving IR had a 2.8-point lower improvement in OKS (p = 0.001), a 6.7-point lower improvement in WOMAC (p = 0.063), and a 12.3-point higher improvement in EQ-VAS (p = 0.281) than patients receiving FTR. IR does not provide long-term benefits to patient recovery after primary uncomplicated TKA under the current rehabilitation regime. KW - total knee arthroplasty KW - fast track rehabilitation KW - inpatient rehabilitation KW - postoperative rehabilitation KW - patient reported outcome measures Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-297322 SN - 2075-4426 VL - 12 IS - 11 ER - TY - JOUR A1 - Seiler, Jonas A1 - Ebert, Regina A1 - Rudert, Maximilian A1 - Herrmann, Marietta A1 - Leich, Ellen A1 - Weißenberger, Manuela A1 - Horas, Konstantin T1 - Bone metastases of diverse primary origin frequently express the VDR (vitamin D receptor) and CYP24A1 JF - Journal of Clinical Medicine N2 - Active vitamin D (1,25(OH)2D3) is known to exert direct anti-cancer actions on various malignant tissues through binding to the vitamin D receptor (VDR). These effects have been demonstrated in breast, prostate, renal and thyroid cancers, which all have a high propensity to metastasise to bone. In addition, there is evidence that vitamin D catabolism via 24-hydroxylase (CYP24A1) is altered in tumour cells, thus, reducing local active vitamin D levels in cancer cells. The aim of this study was to assess VDR and CYP24A1 expression in various types of bone metastases by using immunohistochemistry. Overall, a high total VDR protein expression was detected in 59% of cases (39/66). There was a non-significant trend of high-grade tumours towards the low nuclear VDR expression (p = 0.07). Notably, patients with further distant metastases had a reduced nuclear VDR expression (p = 0.03). Furthermore, a high CYP24A1 expression was detected in 59% (39/66) of bone metastases. There was a significant positive correlation between nuclear VDR and CYP24A1 expression (p = 0.001). Collectively, the VDR and CYP24A1 were widely expressed in a multitude of bone metastases, pointing to a potential role of vitamin D signalling in cancer progression. This is of high clinical relevance, as vitamin D deficiency is frequent in patients with bone metastases. KW - vitamin D receptor KW - VDR KW - CYP24A1 KW - bone metastasis KW - vitamin D Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-297377 SN - 2077-0383 VL - 11 IS - 21 ER - TY - JOUR A1 - Kippnich, Maximilian A1 - Duempert, Maximilian A1 - Schorscher, Nora A1 - Jordan, Martin C. A1 - Kunz, Andreas S. A1 - Meybohm, Patrick A1 - Wurmb, Thomas T1 - Simultaneous treatment of trauma patients in a dual room trauma suite with integrated movable sliding gantry CT system: an observational study JF - Scientific Reports N2 - The trauma center of the University Hospital Wuerzburg has developed an advanced trauma pathway based on a dual-room trauma suite with an integrated movable sliding gantry CT-system. This enables simultaneous CT-diagnostics and treatment of two trauma patients. The focus of this study was to investigate the quality of the concept based on defined outcome criteria in this specific setting (time from arrival to initiation of CT scan: tCT; time from arrival to initiation of emergency surgery: tES). We analyzed all trauma patients admitted to the hospital’s trauma suite from 1st May 2019 through 29th April 2020. Two subgroups were defined: trauma patients, who were treated without a second trauma patient present (group 1) and patients, who were treated simultaneously with another trauma patient (group 2). Simultaneous treatment was defined as parallel arrival within a period of 20 min. Of 423 included trauma patients, 46 patients (10.9%) were treated simultaneously. Car accidents were the predominant trauma mechanism in this group (19.6% vs. 47.8%, p < 0.05). Prehospital life-saving procedures were performed with comparable frequency in both groups (intubation 43.5% vs. 39%, p = 0.572); pleural drainage 3.2% vs. 2.2%, p = 0.708; cardiopulmonary resuscitation 5% vs. 2.2%, p = 0.387). At hospital admission, patients in group 2 suffered significantly more pain (E-problem according to Advanced Trauma Life Support principles©; 29.2% vs. 45.7%, p < 0.05). There were no significant differences in the clinical treatment (emergency procedures, vasopressor and coagulant therapy, and transfusion of red blood cells). tCT was 6 (4–10) minutes (median and IQR) in group 1 and 8 (5–15.5) minutes in group 2 (p = 0.280). tES was 90 (78–106) minutes in group 1 and 99 (97–108) minutes in group 2 (p = 0.081). The simultaneous treatment of two trauma patients in a dual-room trauma suite with an integrated movable sliding gantry CT-system requires a medical, organizational, and technical concept adapted to this special setting. Despite the oftentimes serious and life-threatening injuries, optimal diagnostic and therapeutic procedures can be guaranteed for two simultaneous trauma patients at an individual medical level in consistent quality. KW - dual-room trauma suite KW - movable sliding gantry KW - CT Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-299695 VL - 12 IS - 1 ER - TY - JOUR A1 - Pereira, Ana Rita A1 - Trivanović, Drenka A1 - Stahlhut, Philipp A1 - Rudert, Maximilian A1 - Groll, Jürgen A1 - Herrmann, Marietta T1 - Preservation of the naïve features of mesenchymal stromal cells in vitro: Comparison of cell- and bone-derived decellularized extracellular matrix JF - Journal of Tissue Engineering N2 - The fate and behavior of bone marrow mesenchymal stem/stromal cells (BM-MSC) is bidirectionally influenced by their microenvironment, the stem cell niche, where a magnitude of biochemical and physical cues communicate in an extremely orchestrated way. It is known that simplified 2D in vitro systems for BM-MSC culture do not represent their naïve physiological environment. Here, we developed four different 2D cell-based decellularized matrices (dECM) and a 3D decellularized human trabecular-bone scaffold (dBone) to evaluate BM-MSC behavior. The obtained cell-derived matrices provided a reliable tool for cell shape-based analyses of typical features associated with osteogenic differentiation at high-throughput level. On the other hand, exploratory proteomics analysis identified native bone-specific proteins selectively expressed in dBone but not in dECM models. Together with its architectural complexity, the physico-chemical properties of dBone triggered the upregulation of stemness associated genes and niche-related protein expression, proving in vitro conservation of the naïve features of BM-MSC. KW - decellularization KW - bone model KW - stem cell niche KW - stemness KW - osteogenesis KW - 3D models Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-268835 VL - 13 ER - TY - JOUR A1 - von Hertzberg-Boelch, Sebastian Philipp A1 - Luedemann, Martin A1 - Rudert, Maximilian A1 - Steinert, Andre F. T1 - PMMA bone cement: antibiotic elution and mechanical properties in the context of clinical use JF - Biomedicines N2 - This literature review discusses the use of antibiotic loaded polymethylmethacrylate bone cements in arthroplasty. The clinically relevant differences that have to be considered when antibiotic loaded bone cements (ALBC) are used either for long-term implant fixation or as spacers for the treatment of periprosthetic joint infections are outlined. In this context, in vitro findings for antibiotic elution and material properties are summarized and transferred to clinical use. KW - spacer KW - bone cement KW - PMMA KW - polymethylmethacrylate KW - periprosthetic infection KW - antibiotic elution Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-281708 SN - 2227-9059 VL - 10 IS - 8 ER - TY - JOUR A1 - Stratos, Ioannis A1 - Rinas, Ingmar A1 - Schröpfer, Konrad A1 - Hink, Katharina A1 - Herlyn, Philipp A1 - Bäumler, Mario A1 - Histing, Tina A1 - Bruhn, Sven A1 - Müller-Hilke, Brigitte A1 - Menger, Michael D. A1 - Vollmar, Brigitte A1 - Mittlmeier, Thomas T1 - Effects on bone and muscle upon treadmill interval training in hypogonadal male rats JF - Biomedicines N2 - Testosterone deficiency in males is linked to various pathological conditions, including muscle and bone loss. This study evaluated the potential of different training modalities to counteract these losses in hypogonadal male rats. A total of 54 male Wistar rats underwent either castration (ORX, n = 18) or sham castration (n = 18), with 18 castrated rats engaging in uphill, level, or downhill interval treadmill training. Analyses were conducted at 4, 8, and 12 weeks postsurgery. Muscle force of the soleus muscle, muscle tissue samples, and bone characteristics were analyzed. No significant differences were observed in cortical bone characteristics. Castrated rats experienced decreased trabecular bone mineral density compared to sham-operated rats. However, 12 weeks of training increased trabecular bone mineral density, with no significant differences among groups. Muscle force measurements revealed decreased tetanic force in castrated rats at week 12, while uphill and downhill interval training restored force to sham group levels and led to muscle hypertrophy compared to ORX animals. Linear regression analyses showed a positive correlation between bone biomechanical characteristics and muscle force. The findings suggest that running exercise can prevent bone loss in osteoporosis, with similar bone restoration effects observed across different training modalities. KW - osteoporosis KW - muscle KW - force KW - bone KW - micro-CT KW - training Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-319266 SN - 2227-9059 VL - 11 IS - 5 ER - TY - THES A1 - Seiler, Jonas T1 - Die Expression des Vitamin-D-Rezeptors und der 24-Hydroxylase in Knochenmetastasen unterschiedlicher Entität T1 - Vitamin-D-receptor- and CYP24A1- expression in bone metastases of different primary origin N2 - Knochenmetastasen sind unter den drei häufigsten Manifestationsorten metastatischer Absiedelungen von fortgeschrittenen Tumorerkrankungen. Dabei sind insbesondere Patientinnen und Patienten mit Prostata- und Mammakarzinom von Knochenmetastasen betroffen. Diese Knochenmetastasen führen häufig zu einer deutlichen Verschlechterung der Lebensqualität und zu einer Begrenzung der Therapieoptionen auf lediglich palliative Ansätze. Die biologisch aktive Form von Vitamin D3, 1,25(OH)2-Vitamin D3, zeigt in präklinischen Studien antiproliferative und differenzierende Effekte auf Tumorzellen (101, 102, 104), die haupsächlich durch die Bindung an den Vitamin D-Rezeptor (VDR) vermittelt werden. Darüberhinaus konnte präklinisch gezeigt werden, dass eine niedrige Expression des VDRs, ligandenunabhängig, die Knochenmetastasierung und das Tumorwachstum begünstigt (118). Eine niedrige VDR-Expression ist in Primärtumoren in klinischen Studien mit aggressiven Tumoreigenschaften assoziiert (111, 113, 115) und kann zudem mit einer erhöhten/früheren ossären Metastasierung einhergehen (167). Zudem gibt es Hinweise auf einen dysregulierten 1,25(OH)2-Vitamin D3-Katabolismus durch eine erhöhte Expression des 1,25(OH)2-Vitamin D3 katabolisierenden Enzyms CYP24A1/24-Hydroxylase in primärem Tumorzellen (70, 121, 122). Durch die Untersuchungen der Primärtumoren ist damit zu hypothetisieren, dass die Expression des VDRs und von CYP24A1 bei der Tumorprogression und Knochenmetastasierung von Bedeutung sein könnte. Entsprechende Untersuchungen des VDRs und der 24-Hydroxylase in Knochenmetastasen fehlen allerdings. Deshalb wurde in dieser Arbeit die Expression des VDRs und von CYP24A1 in Knochenmetastasen unterschiedlicher Primärtumoren von 66 Patientinnen und Patienten untersucht und mögliche Assoziationen mit aggressiven Tumoreigenschaften analysiert. Der VDR konnte sowohl im Zytoplasma als auch im Nukleus nachgewiesen werden, während CYP24A1 nur im Zytoplasma lokalisiert war. Dabei wiesen insgesamt 71 % der Knochenmetastasen eine hohe VDR-Expression im Nukleus und 56 % im Zytoplasma auf. 59 % der Knochenmetastasen wiesen eine hohe Expression des VDRs insgesamt auf. CYP24A1 war ebenso in 59 % der Knochenmetastasen hoch exprimiert. Bei der Auswertung des Zusammenhangs zwischen den TNM-Stadien und des Gradings zeigte sich ein nicht signifikanter Trend von schlecht differenzierten Tumoren hin zu einer niedrigeren nukleären VDR-Expression (p=0.07, siehe Abbildung 33). Bezüglich der T-Stadien zeigten sich keine Unterschiede der Expression des VDRs und von CYP24A1 in den Knochenmetastasen zwischen lokal fortgeschrittenen und kleinen Primärtumoren. Weiterhin hatten Patientinnen und Patienten mit Lymphknotenmetastasen tendenziell eine verminderte VDR- und auch CYP24A1-Expression in den Knochenmetastasen im Vergleich zu Patienten und Patientinnen ohne Lymphknotenmetastasen (pVDR=0.15, pCYP24A1=0.06, siehe Abbildung 35). Außerdem hatten Patientinnen und Patienten mit multiple metastasierten Tumoren eine signifikant niedrigere nukleäre VDR- und auch CYP24A1-Expression im Vergleich zu Patientinnen und Patienten mit ausschließlich ossärer Metastasierung (pVDR=0.03, pCYP24A1=0.01, Abbildung 36). Die Proteinexpression des VDRs- und von CYP24A1 korrelierten signifikant (p=0.001). Somit konnte mit dieser Arbeit die Proteinexpression des VDRs und von CYP24A1 in Knochenmetastasen durch Immunhistologie nachgewiesen werden. Insgesamt wurde der VDR und CYP24A1 von Knochenmetastasen diverser Entität unterschiedlich stark exprimiert. Jedoch könnten insbesondere Patienten mit VDR-exprimierenden Knochenmetastasen von einer Vitamin D3-Supplementierung profitieren, die häufig einen 25-OH-Vitamin D3 Mangel zeigen (165, 166). Ebenso könnte eine Untersuchung auf einen niedrigen VDR-Status in Primärtumoren dabei helfen, Krebspatienten mit einem hohen Metastasierungsrisiko zu identifizieren. Allerdings sind weitere und größere Studien inbesondere mit Evaluation des gesamten Vitamin D-Metabolismus und -Signalwegs notwendig, um diesen Zusammenhang weiter zu untersuchen. N2 - Bone metastases are among the three most frequent sites of metastatic manifestation of late-stage cancers, particularly of prostate and breast cancers. Bone metastases often reduce patient’s quality of life due to skeletal-related events. Additionally, bone metastatic tumor treatment is predominantly restricted to palliative measures. In preclinical studies, the biologically active form of vitamin D3, 1,25(OH)2-vitamin D3, has been demonstrated to have antiproliferative and differentiating effects on cancer cells (101, 102, 104), which are mostly mediated by binding to the vitamin D receptor (VDR). Moreover, the VDR expression itself may affect cancer growth and the metastatic potential to bone. For example, preclinically, it has been shown that VDR knockdown promotes bone metastases manifestation and growth (118). Furthermore, low VDR expression is associated to aggressive cancer characteristics in primary cancers (111, 113, 115) and also linked to earlier bone metastasis manifestation in breast cancer (120). In addition, there is evidence that 1,25(OH)2-vitamin D3- catabolism is altered in cancer cells. Thus, inactivation of local 1,25(OH)2-vitamin D3-levels in cancer cells may be increased (70, 121, 122). VDR and CYP24A1 expression could therefore be important concerning cancer progression and bone metastases manifestation and growth. However, there are currently no reports of studies investigating VDR expression and vitamin D-metabolism in bone metastases. The aim of this study was hence to assess VDR and CYP24A1 (vitamin D-catabolizing enzyme) expression in bone metastases of 66 patients secondary to prostate-, breast-, kidney-, lung-, follicular thyroid- and colorectal cancers using immunohistochemistry (132). While the VDR was localised in the nucleus and cytoplasm, CYP24A1 was identified in the cytoplasm only. A high VDR nuclear protein expression was detected in 47/66 (71 %) and cytoplasmatic in 37/66 (56 %). 39/66 (59 %) of bone metastases had a high total VDR expression. CYP24A1 was also strongly expressed in 39/66 (59 %) of bone metastases. Expression levels were correlated to patient data and cancer characteristics. There was a non-significant trend of high-grade cancers towards low nuclear VDR expression (p=0.07, see figure 33). Additionally, patients with lymph node metastases (N-stage) tended to have a reduced bone metastatic VDR and CYP24A1 expression compared to patients without lymph node metastases (pVDR=0.15, pCYP24A1=0.06, see figure 35). There was no difference of VDR and CYP24A1 expression in bone metastases between locally advanced and small primary cancers (T-stage). Interestingly, patients with further metastases other than bone metastases had reduced nuclear VDR and CYP24A1 levels compared to patients without other distant metastases (pVDR=0.03, pCYP24A1=0.01, see figure 36). Nuclear VDR and CYP24A1 expression showed a significant positive correlation (p=0.001). In conclusion, this study demonstrated that the VDR and CYP24A1 are widely expression in bone metastases of various origin. Therefore, patients with VDR-expressing bone metastases could, in particular, benefit from vitamin D3-supplementation, as vitamin D deficiency is frequent in patients with bone metastases (165, 166). Additionally, screening for a low VDR status in primary cancers could help to identify cancer patients at a high risk of metastasis. However, further and larger studies, that evaluate the entire vitamin D metabolism and signalling pathway, are needed to investigate this association. KW - Vitamin D3 KW - Vitamin D KW - Vitamin D-Rezeptor KW - Knochenmetastasen KW - CYP24A1 KW - vitamin d KW - vitamin d receptor KW - bone metastases KW - vdr KW - Knochenmetastase KW - Metastase Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-321827 ER - TY - JOUR A1 - Wang, Chenglong A1 - Stöckl, Sabine A1 - Li, Shushan A1 - Herrmann, Marietta A1 - Lukas, Christoph A1 - Reinders, Yvonne A1 - Sickmann, Albert A1 - Grässel, Susanne T1 - Effects of extracellular vesicles from osteogenic differentiated human BMSCs on osteogenic and adipogenic differentiation capacity of naïve human BMSCs JF - Cells N2 - Osteoporosis, or steroid-induced osteonecrosis of the hip, is accompanied by increased bone marrow adipogenesis. Such a disorder of adipogenic/osteogenic differentiation, affecting bone-marrow-derived mesenchymal stem cells (BMSCs), contributes to bone loss during aging. Here, we investigated the effects of extracellular vesicles (EVs) isolated from human (h)BMSCs during different stages of osteogenic differentiation on the osteogenic and adipogenic differentiation capacity of naïve (undifferentiated) hBMSCs. We observed that all EV groups increased viability and proliferation capacity and suppressed the apoptosis of naïve hBMSCs. In particular, EVs derived from hBMSCs at late-stage osteogenic differentiation promoted the osteogenic potential of naïve hBMSCs more effectively than EVs derived from naïve hBMSCs (naïve EVs), as indicated by the increased gene expression of COL1A1 and OPN. In contrast, the adipogenic differentiation capacity of naïve hBMSCs was inhibited by treatment with EVs from osteogenic differentiated hBMSCs. Proteomic analysis revealed that osteogenic EVs and naïve EVs contained distinct protein profiles, with pro-osteogenic and anti-adipogenic proteins encapsulated in osteogenic EVs. We speculate that osteogenic EVs could serve as an intercellular communication system between bone- and bone-marrow adipose tissue, for transporting osteogenic factors and thus favoring pro-osteogenic processes. Our data may support the theory of an endocrine circuit with the skeleton functioning as a ductless gland. KW - extracellular vesicles KW - mesenchymal stem cells KW - osteogenic potential KW - osteogenic differentiation KW - adipogenic differentiation KW - ECM remodeling KW - bone regeneration Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-286112 SN - 2073-4409 VL - 11 IS - 16 ER -